Discover
RCUS
Arcus Biosciences, Inc.
28.92
100 x undefined
200 x undefined
bid
ask
-
1.91
6.20%
150 @ 04:00 PM
30.05 +1.13 (3.91%)
| Ytd | 21.36% | |
| 1y | 236.67% |
28.77
day range
31.32
8.03
52 week range
31.73
| Open | 30.98 | Prev Close | 30.83 | Low | 28.77 | High | 31.32 | Mkt Cap | 3.64B |
| Vol | 1.61M | Avg Vol | 1.31M | EPS | -3.17 | P/E | N/A | Forward P/E | -9.93 |
| Beta | 0.84 | Short Ratio | 12.25 | Inst. Own | 72.40% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-05 | 50-d Avg | 25.28 | 200-d Avg | 21.67 | 1yr Est | 35.75 |
RCUS News
benzinga.com
Arcus Biosciences Announces Publication In Nature Describing New Research From The ARC-20 Study Show
This is the first study to comprehensively interconnect clinical outcomes from patients receiving a
businesswire.com
New Research Published in Nature Links Clinical Activity with HIF‑2a Biology in Advanced Kidney Canc
HAYWARD, Calif.--(BUSINESS WIRE)--Arcus Biosciences, Inc. (NYSE: RCUS), a clinical-stage, global bio
benzinga.com
Arcus Biosciences Enters Clinical Trial Collaboration And Supply Agreement With Bristol Myers Squibb
Arcus Biosciences, Inc. (NYSE:RCUS), a clinical-stage, global biopharmaceutical company focused on d